Featured Research

from universities, journals, and other organizations

Second Chance For Dangerous T-cells

Date:
June 26, 2009
Source:
Ludwig-Maximilians-Universität München
Summary:
Any of the immune system's T-cells that could attack the body's own tissue are either driven to cell death or reeducated to become a kind of law enforcer that could actually be used in therapies. Which of these alternatives occurs may depend on the age of the cells, according to new research.

The immune system's T-cells react to foreign protein fragments and therefore are crucial to combating viruses and bacteria. Errant cells that attack the body's own material are in most cases driven to cell death. Some of these autoreactive T-cells, however, undergo a kind of reeducation to become "regulatory T-cells" that keep other autoreactive T-cells under control. A group led by immunologist Professor Ludger Klein of LMU Munich has now shown that the developmental stage of an autoreactive T-cell is decisive to its ultimate destiny.

Related Articles


Young autoreactive T-cells are very readily reeducated into regulatory T-cells. Under identical conditions, however, older T-cells become fully activated and can cause damage – they are in a way resistant to reeducation. "We now intend to study at the molecular level what makes a T-cell accessible for reeducation," said Klein, "because then it may be possible to convert even normal adult T-cells, which can be obtained easily and in great numbers from blood. Possibly, they could then be used as regulatory T-cells in therapies for autoimmune diseases such as type-1 diabetes or multiple sclerosis: these are diseases that are triggered by uncontrolled autoreactive T-cells." (PNAS, 10 June 2009)

During their development in the thymus gland, a kind of 'T-cell school', every T-cell is fitted out with its own personal receptor. The diversity of these receptors allows the immune system to respond to nearly all pathogens. Since T-cell receptors are all randomly constructed, there is also a constant production of T-cells in the thymus that may recognize and attack the body's own structures. "Most of these dangerous autoreactive T-cells, though, are sorted out in a screening process before they leave the thymus," Klein reported. "This negative selection, that is the elimination of autoreactive T-cells that would otherwise attack their own organism, is an important requirement for immune tolerance."

But not all autoreactive T-cells are driven to cell death. Some of them are 'reeducated' into so-called regulatory T-cells. While these still possess a T-cell receptor that targets the body's own structures, they have been reprogrammed during their development in the thymus so that they can no longer cause any damage. In fact, it is "quite the opposite," as Klein explained. "They even keep other nearby errant T -cells under control. This is why the mechanisms for the creation of regulatory T-cells are of enormous practical interest. Deciphering these processes could lead to new therapeutic approaches for autoimmune diseases such as multiple sclerosis, rheumatic arthritis and type-1 diabetes, which are triggered by autoreactive T-cells."

Klein and his colleagues are working on a study into unexplained aspects of regulatory T-cells: How can negative selection, i.e. induced cell death, and reprogramming into regulatory T-cells both take place in the thymus gland, right alongside each other? Why does apparently the same trigger drive some cells to 'suicide' while bringing on a 'reeducation process' in others? "One largely popular hypothesis among immunologists in answer to these questions is based on the fact that T-cells can only recognize their target structures if they have them presented to them by other immune cells," said Klein. "Since there are various subspecies of these antigen-presenting cells in the thymus, we tested whether some of them are possibly specialized in controlling one or the other T-cell destinies – with a negative result."

Instead, it turned out that the developmental stage – the 'age' as it were – of the T-cells is crucial. This was even observable in vitro: Young T-cells are very readily reeducated into regulatory T-cells, while older T-cells are largely 'resistant to reeducation' under identical conditions. "It is important for us to understand this 'educability' at a molecular level," Klein said, "because then we might be able to manipulate adult, non-autoreactive T-cells to our needs, since they can be obtained in the millions from the blood of patients. Young T-cells, on the other hand, only exist in the thymus. We will now investigate whether there is a specific time window in the life of a young T-cell that allows negative selection or reprogramming into regulatory T-cells. We are also trying to decode the molecular switch inside T-cells that controls this cell-autonomous switching as a response to external signals."


Story Source:

The above story is based on materials provided by Ludwig-Maximilians-Universität München. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wirnsberger et al. Regulatory T cell differentiation of thymocytes does not require a dedicated antigen-presenting cell but is under T cell-intrinsic developmental control. Proceedings of the National Academy of Sciences, 2009; DOI: 10.1073/pnas.0901877106

Cite This Page:

Ludwig-Maximilians-Universität München. "Second Chance For Dangerous T-cells." ScienceDaily. ScienceDaily, 26 June 2009. <www.sciencedaily.com/releases/2009/06/090615161713.htm>.
Ludwig-Maximilians-Universität München. (2009, June 26). Second Chance For Dangerous T-cells. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2009/06/090615161713.htm
Ludwig-Maximilians-Universität München. "Second Chance For Dangerous T-cells." ScienceDaily. www.sciencedaily.com/releases/2009/06/090615161713.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) — An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins